15202 A phase 3 study of 0.045% tazarotene lotion for once-daily treatment of moderate to severe acne vulgaris
2020 ◽
Vol 83
(6)
◽
pp. AB144
2019 ◽
Vol 19
(1)
◽
pp. 70-77
◽
2019 ◽
Vol 19
(1)
◽
pp. 78-85
◽
2008 ◽
Vol 59
(5)
◽
pp. 792-800
◽
Keyword(s):
2019 ◽
Vol 5
(3)
◽
pp. 199
◽
Keyword(s):